{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:28:43Z","timestamp":1761503323598,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.yebeh.2011.03.038","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T16:27:17Z","timestamp":1307118437000},"page":"306-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: An underdiagnosed entity?"],"prefix":"10.1016","volume":"21","author":[{"given":"Souhel","family":"Najjar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Ghiasian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Zagzag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2011.03.038_bb0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0015","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"55","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2009.09.004","article-title":"Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?","volume":"287","author":"Blanc","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0030","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0035","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03379.x","article-title":"Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma","volume":"149","author":"Knudsen","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.transci.2008.09.005","article-title":"Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis","volume":"39","author":"Mazzi","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0050","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1212\/WNL.56.6.814","article-title":"Encephalitis associated with glutamic acid decarboxylase autoantibodies","volume":"56","author":"Marchiori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.05.015","article-title":"Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies","volume":"199","author":"Mat\u00e0","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0060","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-010-5476-9","article-title":"Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil","volume":"257","author":"Saidha","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2010.06.002","article-title":"Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report","volume":"19","author":"Cianci","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5692\/clinicalneurol.50.92","article-title":"A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody","volume":"50","author":"Kobayakawa","year":"2010","journal-title":"Rinsho Sinkeigaku"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0075","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2011.03.038_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00296356","article-title":"Periodic acid\u2013Schiff (PAS)-positive deposits in brain following kainic acid-induced seizures: relationships to fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown","volume":"89","author":"Bennett","year":"1995","journal-title":"Acta Neuropathol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:23:05Z","timestamp":1761502985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505011001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1525505011001661"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.03.038","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: An underdiagnosed entity?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}